Loading clinical trials...
Loading clinical trials...
Olfactory Cleft Obstruction and Electrophysiological Olfactory Bulb Generated Beta Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Conditions
Interventions
Dupilumab - Standard Dose
Locations
1
United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Start Date
May 1, 2025
Primary Completion Date
April 30, 2027
Completion Date
December 31, 2027
Last Updated
May 14, 2025
NCT05364125
NCT02912468
Lead Sponsor
Northwestern University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions